TransgenderismNCT04515654
Supporting Trans Identities and Occupational Justice Through Narrative Informed Theatre: Supporting Trans Identities and Occupational Justice Through Narrative Informed Theatre
A study testing IDEAS (Identity Evolution and Sharing) Performance in people with Transgenderism and Stigma, Social, run by Indiana University at 1 site in United States.
Trial summary
Importance: Societal stigma gravely impedes occupational justice for trans individuals, producing vast health disparities for this population. Objective: Test feasibility and impact of an intervention to reduce stigma and improve trans wellbeing Design: Convergent parallel mixed methods Setting: Community/Webinar… Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Transgenderism, Stigma, Social
- What is being tested?
- IDEAS (Identity Evolution and Sharing) Performance
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 42 participants
- Where
- 1 siteUnited States
- Study dates
- 15 Jan 2019to 15 May 2020
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- age 18 or older
Who cannot join
- none
Trial locations and contacts
1 site in 1 country.
United States1 site
Indiana University Purdue University Indianapolis
Indianapolis, Indiana, 46202
About this study
Official title: Supporting Trans Identities and Occupational Justice Through Narrative Informed Theatre: A Mixed-methods Pilot Study
Importance: Societal stigma gravely impedes occupational justice for trans individuals, producing vast health disparities for this population.
Objective: Test feasibility and impact of an intervention to reduce stigma and improve trans wellbeing Design: Convergent parallel mixed methods Setting: Community/Webinar Participants: 42 audience members and 6 trans interviewees Intervention: Virtual, narrative-informed play reading and moderated discussion about gender diversity and affirmative care Outcomes and Measures: The valid and reliable Acceptance and Action Questionnaire - Stigma (AAQ-S) assesses stigma beliefs; An open-ended qualitative question assesses trans interviewees' experiences
- Conditions
- Transgenderism, Stigma, Social
- Being tested
- IDEAS (Identity Evolution and Sharing) Performance
- Keywords
- gender, drama, disability studies, qualitative, stigma, affirmative care, minority health
- Medical subject headings
- Transsexualism, Social Stigma, Coitus
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
IDEAS (Identity Evolution and Sharing) PerformanceOther
Also called Performance
60 minute webinar depicting first-hand stories of transgender and gender non-conforming individuals followed by expert panel/talk-back
| Study group | Role | What they receive |
|---|---|---|
| Audience participants | Experimental | Community members viewed the performance (intervention) and completed pre/post stigma questionnaire Receives: Other: IDEAS (Identity Evolution and Sharing) Performance |
What is being measured
The primary outcome is the main question the study is designed to answer.
Acceptance and Action Questionnaire-stigma
The Acceptance and Action Questionnaire - Stigma (AAQ-S) survey
Measured: 1 week
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted17 Aug 2020
- Study start15 Jan 2019
- Primary completion15 May 2020
- Study completion15 May 2020
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for TransgenderismStudies of the same condition, open and under way.
- More trials run by Indiana UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 42 participants (actual)
Sponsor and investigators
- Lead sponsor
- Indiana University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Sally Wasmuth, Indiana University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04515654
- Sponsor's protocol ID
- 1906677292
- Status last verified
- Aug 2020
- First submitted
- 20 May 2020
- Last updated
- 17 Aug 2020
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 17 Aug 2020. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Supporting Trans Identities and Occupational Justice Through Narrative Informed Theatre: A Mixed-methods Pilot Study
- ClinicalTrials.gov ID
- NCT04515654
- Acronym / sponsor ID
- 1906677292
- Conditions
- Transgenderism, Stigma, Social
- Keywords
- gender, drama, disability studies, qualitative, stigma, affirmative care, minority health
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 42 participants (actual)
- Lead sponsor
- Indiana UniversityUniversity, hospital or other
- Study start
- 15 Jan 2019 (actual)
- Primary completion
- 15 May 2020 (actual)
- Study completion
- 15 May 2020 (actual)
- First posted
- 17 Aug 2020 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Importance: Societal stigma gravely impedes occupational justice for trans individuals, producing vast health disparities for this population.
Objective: Test feasibility and impact of an intervention to reduce stigma and improve trans wellbeing Design: Convergent parallel mixed methods Setting: Community/Webinar Participants: 42 audience members and 6 trans interviewees Intervention: Virtual, narrative-informed play reading and moderated discussion about gender diversity and affirmative care Outcomes and Measures: The valid and reliable Acceptance and Action Questionnaire - Stigma (AAQ-S) assesses stigma beliefs; An open-ended qualitative question assesses trans interviewees' experiences
Study design
- Primary purpose
- Other
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Audience participants | Experimental | Other: IDEAS (Identity Evolution and Sharing) PerformanceCommunity members viewed the performance (intervention) and completed pre/post stigma questionnaire |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (1 listed)
- age 18 or older
Key exclusion criteria (1 listed)
- none
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| IDEAS (Identity Evolution and Sharing) PerformanceAlso: Performance60 minute webinar depicting first-hand stories of transgender and gender non-conforming individuals followed by expert panel/talk-back | Other | Audience participants |
Primary outcome
Acceptance and Action Questionnaire-stigma
Time frame: 1 week
The Acceptance and Action Questionnaire - Stigma (AAQ-S) survey
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 17 Aug 2020.
- Individual participant dataSharing planned: No
Related trials for Transgenderism
Enrolling by invitation
Metoidioplasty and Phalloplasty Surgery Decision Making
Gender Dysphoria, Gender Dysphoria, Adult
RecruitingPhase 4
Androgen Effects on the Reproductive Neuroendocrine Axis, 2025 Version
Transgenderism, Reproductive Issues
RecruitingObservational study
Effects of Cross-sex Hormone Therapy on Eating Behavior, Metabolism, Energy Balance and Cardiovascular System
Transsexualism, Transgenderism
Active, not recruitingObservational study
Cardiometabolic Health in Transgender Males
Transgender, Transgenderism
RecruitingObservational study
Transgender Men, Non-binary Persons and Testosterone Treatment BODY IDENTITY CLINIC
Transgenderism
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing IDEAS (Identity Evolution and Sharing) Performance in people with Transgenderism and Stigma, Social, run by Indiana University at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 17 Aug 2020. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Acceptance and Action Questionnaire-stigma (time frame: 1 week). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Aug 2020.